Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3082202 | 0.89 | ALDH1A1 (0.47) | ALDH1A1TSHRTHRBHPGDNPC1 | |
| SCHEMBL809306 | 0.82 | ALDH1A1 (0.45) | ALDH1A1TSHRTHRBHPGDCES2 | |
| SCHEMBL809305 | 0.82 | ALDH1A1 (0.45) | ALDH1A1TSHRTHRBHPGDCES2 | |
| Ether SCHEMBL29157255 | 0.81 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRB | |
| SCHEMBL898727 | 0.81 | HCAR2 (0.43) | ALDH1A1TSHRTHRBCES2 | |
| SCHEMBL898728 | 0.81 | HCAR2 (0.43) | ALDH1A1TSHRTHRBCES2 | |
| SCHEMBL28370469 | 0.81 | ALDH1A1 (0.43) | ALDH1A1TSHRTHRBHPGDCES2 | |
| SCHEMBL28506569 | 0.80 | PTGS1 (0.33) | KDM4ESMN1; SMN2TDP1L3MBTL1 | |
| SCHEMBL3388405 | 0.79 | CES2 (0.46) | ALDH1A1TSHRTHRBCES2 | |
| SCHEMBL28126163 | 0.79 | CES2 (0.46) | ALDH1A1TSHRTHRBCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2968090-B1 | METHOD OF REMOVING POLYMERIZED COATINGS FROM HUMAN NAILS, POLYMERIZED COATING FOR HUMAN NAILS HAVING IMPROVED REMOVABILITY, AND TWO PACKAGE SYSTEM | MYCONE DENTAL SUPPLY COMPANY INC (US) | 2021-06-02 | — | — | EP | disclosed |
| EP-2525773-B1 | EASILY APPLIABLE, STORAGE STABLE, RADIATION-CURABLE, PIGMENTED, ARTIFICIAL NAIL GEL COATINGS | MYCONE DENTAL SUPPLY CO INC (US) | 2020-02-12 | — | — | EP | disclosed |
| EP-2547730-B1 | METHOD OF PREPARATION OF RADIATION-CURABLE COLORED ARTIFICIAL NAIL GELS | MYCONE DENTAL SUPPLY COMPANY INC (US) | 2019-07-10 | — | — | EP | disclosed |
| US-20190151222-A1 | ONE PART ARTIFICIAL NAIL SCULPTING COMPOSITIONS AND METHODS WITHOUT REACTIVE OLIGOMERS | NAIL ALLIANCE, LLC | 2019-05-23 | — | — | US | disclosed |
| US-20190151223-A1 | ONE PART ARTIFICIAL NAIL COMPOSITIONS | MYCONE DENTAL SUPPLY CO INC (US) | 2019-05-23 | — | — | US | disclosed |
| US-20190125652-A1 | One Part Acrylic Nail Formulation | MYCONE DENTAL SUPPLY CO INC (US) | 2019-05-02 | — | — | US | disclosed |
| EP-3471831-A1 | ONE PART ACRYLIC NAIL FORMULATION | Mycone Dental Supply Company, Inc. (US) | 2019-04-24 | — | — | EP | disclosed |
| EP-2363109-B1 | Uv-curable nail coating formulations based on renewable polyols | MYCONE DENTAL SUPPLY COMPANY INC (US) | 2018-09-05 | — | — | EP | disclosed |
| US-20180092827-A1 | ONE PART ACRYLIC NAIL FORMULATION WITH DISCONTINUOUS PHASE | MYCONE DENTAL SUPPLY CO INC (US) | 2018-04-05 | — | — | US | disclosed |
| US-9931284-B2 | Method of removing polymerized coatings for human nails, polymerized coating for human nails having improved removability, and two package system | MYCONE DENTAL SUPPLY COMPANY, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| EP-2547730-A2 | METHOD OF PREPARATION OF RADIATION-CURABLE COLORED ARTIFICIAL NAIL GELS | Mycone Dental Supply Company Inc. (US) | 2013-01-23 | — | — | EP | disclosed |
| US-20120252710-A1 | METHOD AND COMPOSITION FOR REMOVING RADIATION-CURABLE, PIGMENTED, ARTIFICIAL NAIL GEL COATINGS | MYCONE DENTAL SUPPLY CO., INC. (US) | 2012-10-04 | — | — | US | disclosed |
| US-20120004340-A1 | METHOD OF PREPARATION OF RADIATION-CURABLE COLORED ARTIFICIAL NAIL GELS | MYCONE DENTAL SUPPLY COMPANY, INC. (US) | 2012-01-05 | — | — | US | disclosed |
| WO-2011130362-A2 | EASILY APPLIABLE, STORAGE STABLE, RADIATION-CURABLE, PIGMENTED, ARTIFICIAL NAIL GEL COATINGS | MYCONE DENTAL SUPPLY CO., INC. (US) | 2011-10-20 | — | — | WO | disclosed |
| US-20110256079-A1 | Easily appliable, storage stable, radiation-curable, pigmented, artificial nail gel coatings | MYCONE DENTAL CORPORATION | 2011-10-20 | — | — | US | disclosed |
| US-20110256080-A1 | Easily appliable, storage stable, radiation-curable, pigmented, artificial nail gel coatings | MYCONE DENTAL CORPORATION | 2011-10-20 | — | — | US | disclosed |
| US-20110226271-A1 | Method of Preparation of Radiation-Curable Colored Artificial Nail Gels | MYCONE DENTAL SUPPLY COMPANY, INC. (US) | 2011-09-22 | — | — | US | disclosed |
| WO-2011115795-A2 | METHOD OF PREPARATION OF RADIATION-CURABLE COLORED ARTIFICIAL NAIL GELS | MYCONE DENTAL SUPPLY COMPANY, INC. (US) | 2011-09-22 | — | — | WO | disclosed |
| EP-2363109-A2 | Uv-curable nail coating formulations based on renewable polyols | Mycone Dental Supply Company, Inc. (US) | 2011-09-07 | — | — | EP | disclosed |
| US-20110182837-A1 | UV-CURABLE NAIL COATING FORMULATIONS BASED ON RENEWABLE POLYOLS | MYCONE DENTAL SUPPLY CO., INC. (US) | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190151223-A1 | ONE PART ARTIFICIAL NAIL COMPOSITIONS | POLR1C, PIK3C3, NACA | ALDH1A1 3782/4885TSHR 1716/4885THRB 1902/4885 |
| US-20190151222-A1 | ONE PART ARTIFICIAL NAIL SCULPTING COMPOSITIONS AND METHODS WITHOUT REACTIVE OLIGOMERS | POLR1C, NACA, SUCLG1 | ALDH1A1 2608/4885TSHR 1396/4885THRB 732/4885 |
| US-20180092827-A1 | ONE PART ACRYLIC NAIL FORMULATION WITH DISCONTINUOUS PHASE | POLR1C, NACA, PIK3C3 | ALDH1A1 2055/4885TSHR 1748/4885THRB 853/4885 |
| US-20190125652-A1 | One Part Acrylic Nail Formulation | POLR1C, NACA, PIK3C3 | ALDH1A1 321/4885TSHR 3359/4885THRB 2500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.